Click here to view the clickable sidebar

The IAC Standards and Guidelines
for Nuclear/PET Accreditation

 

Click here for a printer-friendly PDF of the Nuclear/PET Standards

Part C:
Quality Improvement

Section 2C: Quality Improvement Measures

 

STANDARD – QI Measures

 

 

 

2.1C           Facilities are required to have a process in place to evaluate the QI measures outlined in sections 2.1.1C through 2.1.4C.

 

(See Guidelines below for further recommendations.)

 

2.1.1C            Test Appropriateness: The facility must evaluate the appropriateness of the test performed and categorized as:

 

2.1.1.1C             appropriate/usually appropriate;

 

2.1.1.2C             may be appropriate;

 

2.1.1.3C             rarely appropriate / usually not appropriate.

 

 

(See Guidelines below for further recommendations.)

 

2.1.2C            Technical Quality Review: To assess and improve the technical quality of the images and if applicable the safety of procedures being performed. The review must include, but are is not limited to the evaluation of:

 

2.1.2.1C             the clinical images for clarity of images and/or evaluation for suboptimal images or artifact;

 

2.1.2.2C             reproducibility of processed images and/or quantitative results;

 

2.1.2.3C             image display/labeling;

 

2.1.2.4C             correct patient preparation, as specified in the clinical written procedures, at the time of study;

 

2.1.2.5C             verification of administered radioactive dose to prescribed dose listed in protocol;

 

2.1.2.6C             completeness of the study;

 

2.1.2.7C             adherence to the facility imaging acquisition protocols.

 

(See Guidelines below for further recommendations.)

 

2.1.3C            Interpretive Quality Review: The facility must evaluate the quality and accuracy of the interpretation based on the acquired images.  Areas that may be assessed include but are not limited to:

 

2.1.3.1C             interobserver agreement (peer review);

 

2.1.3.2C             intra-observer variability;

 

2.1.3.3C             correlation of interpretation with other diagnostic studies, pathology/surgical results and/or patient outcomes;

 

2.1.3.4C             correlation of intended therapeutic effects with patient response to therapy.

(See Guidelines below for further recommendations.)

 

2.1.4C            Final Report Completeness and Timeliness – The facility must evaluate the final report for completeness and timeliness as required in the Standards.

 

 

Section 2C: Quality Improvement Measures
Guidelines

 

2.1C           Administrative Quality – To assess and improve the administrative quality of the facility’s operation. Areas that may be assessed include, but are not limited to: scheduling back logs; patient wait times; accuracy of patient information during scheduling; completeness of documentation; time from completion of procedure to distribution of final report; patient satisfaction; referring physician satisfaction

 

2.1.1C        All other areas of nuclear medicine are encouraged to measure appropriate use as AUC are published by professional medical organizations.

 

2.1.2C and 2.1.3C           Annual participation in a relevant inter-facility patient simulator exercise (phantom program) may be used to fulfill the annual QI requirement for both the technical and physician performance measurements.